Jan Van Den Brande unpaid staff

Publications Jan Van Den Brande

Avelumab-based neoadjuvant therapy in patients with muscle-invasive bladder cancer (AURA Oncodistinct-004) : a phase 2 multicenter clinical trial

Source
Journal for ImmunoTherapy of Cancer - ISSN 2051-1426-13:5 (2025) p. 1-10
Author(s)
    Jeremy Blanc, Aurelien Carnot, Philippe Barthelemy, Vinciane Casert, Brieuc Sautois, Jan van den Brande, Vincent Vanhaudenarde, Lionel Staudacher, Emmanuel Seront, Veronique Debien, Lieveke Ameye, Nuria Kotecki, Francoise Rothe, Sandrine Rorive, Jean-Christophe Fantoni, Thibault Tricard, Thierry Roumeguere, Ahmad Awada, Nieves Martinez Chanza

WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors : type 1 T-lymphocyte responses are associated with clinical outcome

Source
Journal of hematology and oncology - ISSN 1756-8722-18:1 (2025) p. 1-6
Author(s)

Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle invasive bladder cancer : a multicenter, randomized, non-comparative, phase II study (Oncodistinct 004-AURA trial)

Source
BMC cancer - ISSN 1471-2407-21:1 (2021) p.
Author(s)
    Nieves Martinez Chanza, Louisa Soukane, Philippe Barthelemy, Aurelien Carnot, Thierry Gil, Vinciane Casert, Vincent Vanhaudenarde, Brieuc Sautois, Lionel Staudacher, Jan van den Brande, Stephane Culine, Emmanuel Seront, Marco Gizzi, Simone Albisinni, Thibault Tricard, Jean Christophe Fantoni, Marianne Paesmans, Rafael Caparica, Thierry Roumeguere, Ahmad Awada

Should anti-EGFR agents be used in right-sided RAS wild-type advanced colorectal cancer?

Source
Current colorectal cancer reports - ISSN 1556-3790-15:4 (2019) p. 130-134
Author(s)

Primary cardiac synovial sarcoma of the interatrial septum

Source
Journal of cardiac surgery - ISSN 0886-0440-33:7 (2018) p. 391-392
Author(s)